GINA SCHNURBUSCH: Open Payments
NPI 1861928244 · O FALLON, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$375 in 23 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $263 · 2025 $375
Food & beverage: $375
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $145 |
| Lilly USA, LLC | 2 | $54 |
| PFIZER INC. | 3 | $51 |
| Amgen Inc. | 2 | $39 |
| AstraZeneca Pharmaceuticals LP | 1 | $18 |
| Globus Medical, Inc. | 1 | $17 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $16 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
| GlaxoSmithKline, LLC. | 1 | $14 |
| Phathom Pharmaceuticals, Inc. | 1 | $6 |
Products named: Wegovy, Ozempic, OTEZLA, JARDIANCE, MOUNJARO, AIRSUPRA, NURTEC ODT, Senza.
Industry payments across MO — which companies pay providers there.
